Please provide your email address to receive an email when new articles are posted on . Antimalarials, azathioprine, colchicine, cyclosporine, sulfasalazine and tacrolimus are deemed compatible with ...

Combining an anticancer drug with an antirheumatic produces improved effects against tumors, scientists have discovered. The discovery opens a new path for drug-drug synergy. Scientists at EPFL and ...

A new review published in Calcified Tissue International highlights major advances in understanding and preventing bone loss in people with rheumatoid arthritis (RA), showing that modern antirheumatic ...

Only slightly more than half of patients with newly diagnosed rheumatoid arthritis initiated therapy within 1 year. Objectives: To determine the rate of timely disease-modifying antirheumatic drug ...

Antirheumatic agents are among commonly used drugs associated with adverse hepatic reactions. Sulfasalazine and azathioprine are among the most important causes of acute hepatotoxicity. Because such a ...

Arthritis, a chronic condition characterized by inflammation, is a common disease in the United States. Approximately 43.5% of people in the US living with arthritis experience some sort of limitation ...

For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that most very abnormal ...